CBL’s Technology for Diagnosis and Monitoring of PAD Licensed to Startup

Optical Imaging technology for the assessment of peripheral artery disease (PAD) in diabetic patients, which was developed in Dr. Hielscher’s Clinical Biophotonics Laboratory (CBL) has been licensed to VOTIS Subdermal Imaging Technologies, Ltd. The license includes 10 of the CBL’s patents. The covered technology is being used by VOTIS to develop a suite of medical devices to help people with PAD to receive an accurate assessment of their condition. In this way PAD patients can receive crucial treatment early, even before they have symptoms. This knowledge will help physicians delay or eliminate the need for debilitating amputation. For more information click on the links below.
Biospace News
PRNewswire
AINeurons